Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Ovacome Members' Day /
Latest in ovarian cancer treatment

18th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.05.19
Views: 903
Rating:

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Dr Susana Banerjee talks to ecancer at the Ovacome Member's Day 2019 about the latest in ovarian cancer treatment.

She discusses the importance of clinical trials in progressing with new treatment options giving an example of the SOLO-1 trial examining the use of olaparib.

Dr Banerjee believes that there is a building momentum in progressing clinical trials in ovarian cancer and in particular in the rarer types of the disease.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation